Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer: Why tumours eat tryptophan.

Literature DB >> 21993754

Cancer: Why tumours eat tryptophan.

George C Prendergast.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21993754 DOI： 10.1038/478192a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

17 in total

1. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

Authors: Joshua D Mezrich; John H Fechner; Xiaoji Zhang; Brian P Johnson; William J Burlingham; Christopher A Bradfield
Journal: J Immunol Date: 2010-08-18 Impact factor: 5.422

2. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Authors: Alexander J Muller; James B DuHadaway; P Scott Donover; Erika Sutanto-Ward; George C Prendergast
Journal: Nat Med Date: 2005-02-13 Impact factor: 53.440

3. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.

Authors: Nam Trung Nguyen; Akihiro Kimura; Taisuke Nakahama; Ichino Chinen; Kazuya Masuda; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal: Proc Natl Acad Sci U S A Date: 2010-11-01 Impact factor: 11.205

Review 4. Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway.

Authors: George C Prendergast; Richard Metz; Alexander J Muller
Journal: Am J Pathol Date: 2010-03-12 Impact factor: 4.307

5. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors: Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal: Nature Date: 2011-10-05 Impact factor: 49.962

Review 6. Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors: David H Munn; Andrew L Mellor
Journal: J Clin Invest Date: 2007-05 Impact factor: 14.808

7. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.

Authors: Christoph F A Vogel; Samuel R Goth; Bin Dong; Isaac N Pessah; Fumio Matsumura
Journal: Biochem Biophys Res Commun Date: 2008-08-09 Impact factor: 3.575

8. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors: Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal: Nat Med Date: 2003-09-21 Impact factor: 53.440

Review 9. Creating immune privilege: active local suppression that benefits friends, but protects foes.

Authors: Andrew L Mellor; David H Munn
Journal: Nat Rev Immunol Date: 2008-01 Impact factor: 53.106

Review 10. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors: Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal: Science Date: 2011-03-25 Impact factor: 47.728

47 in total

Review 1. Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

Authors: Srikanth Santhanam; David M Alvarado; Matthew A Ciorba
Journal: Transl Res Date: 2015-08-03 Impact factor: 7.012

2. Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels.

Authors: Yang Pu; Jianpeng Xue; Wubao Wang; Baogang Xu; Yueqing Gu; Rui Tang; Ellen Ackerstaff; Jason A Koutcher; Samuel Achilefu; Robert R Alfano
Journal: J Biomed Opt Date: 2013-08 Impact factor: 3.170

10. Single-shot characterization of enzymatic reaction constants Km and kcat by an acoustic-driven, bubble-based fast micromixer.

Authors: Yuliang Xie; Daniel Ahmed; Michael Ian Lapsley; Sz-Chin Steven Lin; Ahmad Ahsan Nawaz; Lin Wang; Tony Jun Huang
Journal: Anal Chem Date: 2012-08-14 Impact factor: 6.986

Cancer: Why tumours eat tryptophan.

1. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

2. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

3. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.

Review 4. Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway.

5. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Review 6. Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

7. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.

8. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Review 9. Creating immune privilege: active local suppression that benefits friends, but protects foes.

Review 10. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Review 1. Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

2. Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels.

3. A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models.

4. Conformational Plasticity in Human Heme-Based Dioxygenases.

Review 5. Microenvironmental clues for glioma immunotherapy.

6. Altered tryptophan metabolism in human meningioma.

Review 7. How do cancer cells replenish their fuel supply?

8. Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.

9. Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

10. Single-shot characterization of enzymatic reaction constants Km and kcat by an acoustic-driven, bubble-based fast micromixer.